Vaccines, immunology and immunopharmacology are strong research areas at Tampere University. The VACCIM Research Center advances the prevention of infectious diseases through modern vaccines and develops new immunomodulatory / anti-inflammatory treatments for immune-mediated diseases by integrating modern technologies, unique sample collections, and multidisciplinary research.
Effective vaccines rely on the body’s defense system, the immune response. The immune response and inflammation also play a key role in the development of many diseases, and treatments that modulate or suppress these responses are important in the treatment of various inflammatory conditions. VACCIM Research Center develops vaccines for the prevention of conditions such as type 1 diabetes, norovirus infections, and pandemic coronaviruses, and investigates pharmacological therapies for tuberculosis, inflammatory diseases, and allergy.
Within Tampere University’s P4 medicine framework (Predictive, Preventive, Personalized, and Participatory), VACCIM primarily advances disease Prevention through vaccines, and supports Personalization of immunomodulating treatments. The center collaborates closely with national and international partners, strengthening Tampere’s position at the forefront of vaccine development and immunology.